Clinical Trial Update: Raltegravir in the Swiss HIV Cohort Study

View source ↗

Summary

The clinical trial evaluating raltegravir in the Swiss HIV Cohort Study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: University of Zurich | Conditions: HIV Infection | Status: COMPLETED